Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ViiV Healthcare

ViiV Healthcare
2009 FOUNDED
PRIVATE STATUS
601-700 EMPLOYEES
2ndary - Private LATEST DEAL TYPE
2 FINANCING ROUNDS
1 INVESTMENTS
Description

Operator of a global specialist HIV company intended to deliver innovative new options for the care and treatment of people living with HIV/AIDS. The company's products include dolutegravir, zidovudine, fosamprenavi, maraviroc, abacavir, and nelfinavir and delavirdine mesylate and provides nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitor, protease inhibitors, and CCR5 antagonist for the treatment of AIDS.

Formerly Known As
GlaxoSmithKline Newco Limited
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors/Wholesale
Other Industries
Drug Discovery
Other Healthcare
Biotechnology
Primary Office
  • 980 Great West Road
  • Brentford TW8 9GS
  • England, United Kingdom

+44 020 0000 0000

ViiV Healthcare Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ViiV Healthcare‘s full profile, request access.

Request full access to PitchBook

ViiV Healthcare Competitors (43)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CymaBay Therapeutics Formerly PE-Backed Newark, CA 00 00000 00000000 00000
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
000000 Formerly VC-backed Lyon, France 000 000.00 00000000 000.00
00000000 000000000 Corporation West Conshohocken, PA 00 000.00 000000 - 000 000.00
To view this company’s complete list of competitors, request access »

ViiV Healthcare Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000-00000 0000 22-Feb-2016 000000000 00000 00 000 Drug Discovery 000000000 00000
To view this company’s complete investment and acquisition history, request access »

ViiV Healthcare Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore ViiV Healthcare‘s full profile, request access.

Request full access to PitchBook

ViiV Healthcare Executive Team (4)

Name Title Board
Seat
Contact
Info
Deborah Waterhouse Chief Executive Officer
Andries Jerome Chief Financial Officer
John Pottage Jr. Senior Vice President and Chief Scientific and Medical Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »